Global Transcriptome Sequencing Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI05252791

Publication Date:

May 6, 2025

Pages:

120

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Transcriptome Sequencing market size is predicted to grow from US$ 2682 million in 2025 to US$ 6108 million in 2031; it is expected to grow at a CAGR of 14.7% from 2025 to 2031.
Transcriptome sequencing employs high-throughput sequencing technologies to get access to almost all transcripts of specific tissues or cells in a certain state by comprehensive and rapid cDNA sequencing, becoming the basis as well as the starting point for the research of gene expression. The main objectives of transcriptome research include the classification of all transcriptional products, the determination of the transcription structure of genes (such as starting sites, 5鈥� and 3鈥� terminals, splicing patterns, and post-transcriptional modifications), and the changes in the expression levels of individual transcripts during development. This technology has been widely used in biological research, medical and clinical research, and drug development.
The key service providers of Transcriptome Sequencing in the world are Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences and Eurofins Scientific, among which the top five providers account for more than 70% of the market share, and Illumina is the largest service provider. The cost of RNA-Seq has decreased significantly over the past decade, making it more accessible to researchers and clinicians. This cost reduction is driven by advancements in sequencing technologies and economies of scale. Transcriptome sequencing is playing a critical role in identifying patient-specific biomarkers and therapeutic targets. The growing focus on precision medicine is driving adoption in oncology, rare diseases, and pharmacogenomics. Increased funding for genomics and transcriptomics research from governments, non-profits, and private investors is supporting market growth. Initiatives like the Cancer Genome Atlas (TCGA) and Human Cell Atlas (HCA) are driving large-scale transcriptome studies.
The 鈥淭ranscriptome Sequencing Industry Forecast鈥� looks at past sales and reviews total world Transcriptome Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Transcriptome Sequencing sales for 2025 through 2031. With Transcriptome Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transcriptome Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Transcriptome Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Transcriptome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Transcriptome Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transcriptome Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transcriptome Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of Transcriptome Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Coding RNA
Noncoding RNA
Segmentation by Application:
Biomedical Field
Non-medical Field
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
贰耻谤辞蹿颈苍蝉听厂肠颈别苍迟颈蹿颈肠
Roche
Bio-Rad
Agilent Technologies
LabCorp
QIAGEN
Pacific Biosciences
Azenta
BGI Genomics
Novogene
Macrogen
Shanghai ZJ Bio-Tech
Tsingke Biotechnology

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transcriptome Sequencing Market Size (2020-2031)
2.1.2 Transcriptome Sequencing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Transcriptome Sequencing by Country/Region (2020, 2024 & 2031)
2.2 Transcriptome Sequencing Segment by Type
2.2.1 Coding RNA
2.2.2 Noncoding RNA
2.3 Transcriptome Sequencing Market Size by Type
2.3.1 Transcriptome Sequencing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Transcriptome Sequencing Market Size Market Share by Type (2020-2025)
2.4 Transcriptome Sequencing Segment by Application
2.4.1 Biomedical Field
2.4.2 Non-medical Field
2.5 Transcriptome Sequencing Market Size by Application
2.5.1 Transcriptome Sequencing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Transcriptome Sequencing Market Size Market Share by Application (2020-2025)
3 Transcriptome Sequencing Market Size by Player
3.1 Transcriptome Sequencing Market Size Market Share by Player
3.1.1 Global Transcriptome Sequencing Revenue by Player (2020-2025)
3.1.2 Global Transcriptome Sequencing Revenue Market Share by Player (2020-2025)
3.2 Global Transcriptome Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Transcriptome Sequencing by Region
4.1 Transcriptome Sequencing Market Size by Region (2020-2025)
4.2 Global Transcriptome Sequencing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Transcriptome Sequencing Market Size Growth (2020-2025)
4.4 APAC Transcriptome Sequencing Market Size Growth (2020-2025)
4.5 Europe Transcriptome Sequencing Market Size Growth (2020-2025)
4.6 Middle East & Africa Transcriptome Sequencing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Transcriptome Sequencing Market Size by Country (2020-2025)
5.2 Americas Transcriptome Sequencing Market Size by Type (2020-2025)
5.3 Americas Transcriptome Sequencing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transcriptome Sequencing Market Size by Region (2020-2025)
6.2 APAC Transcriptome Sequencing Market Size by Type (2020-2025)
6.3 APAC Transcriptome Sequencing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Transcriptome Sequencing Market Size by Country (2020-2025)
7.2 Europe Transcriptome Sequencing Market Size by Type (2020-2025)
7.3 Europe Transcriptome Sequencing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transcriptome Sequencing by Region (2020-2025)
8.2 Middle East & Africa Transcriptome Sequencing Market Size by Type (2020-2025)
8.3 Middle East & Africa Transcriptome Sequencing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Transcriptome Sequencing Market Forecast
10.1 Global Transcriptome Sequencing Forecast by Region (2026-2031)
10.1.1 Global Transcriptome Sequencing Forecast by Region (2026-2031)
10.1.2 Americas Transcriptome Sequencing Forecast
10.1.3 APAC Transcriptome Sequencing Forecast
10.1.4 Europe Transcriptome Sequencing Forecast
10.1.5 Middle East & Africa Transcriptome Sequencing Forecast
10.2 Americas Transcriptome Sequencing Forecast by Country (2026-2031)
10.2.1 United States Market Transcriptome Sequencing Forecast
10.2.2 Canada Market Transcriptome Sequencing Forecast
10.2.3 Mexico Market Transcriptome Sequencing Forecast
10.2.4 Brazil Market Transcriptome Sequencing Forecast
10.3 APAC Transcriptome Sequencing Forecast by Region (2026-2031)
10.3.1 China Transcriptome Sequencing Market Forecast
10.3.2 Japan Market Transcriptome Sequencing Forecast
10.3.3 Korea Market Transcriptome Sequencing Forecast
10.3.4 Southeast Asia Market Transcriptome Sequencing Forecast
10.3.5 India Market Transcriptome Sequencing Forecast
10.3.6 Australia Market Transcriptome Sequencing Forecast
10.4 Europe Transcriptome Sequencing Forecast by Country (2026-2031)
10.4.1 Germany Market Transcriptome Sequencing Forecast
10.4.2 France Market Transcriptome Sequencing Forecast
10.4.3 UK Market Transcriptome Sequencing Forecast
10.4.4 Italy Market Transcriptome Sequencing Forecast
10.4.5 Russia Market Transcriptome Sequencing Forecast
10.5 Middle East & Africa Transcriptome Sequencing Forecast by Region (2026-2031)
10.5.1 Egypt Market Transcriptome Sequencing Forecast
10.5.2 South Africa Market Transcriptome Sequencing Forecast
10.5.3 Israel Market Transcriptome Sequencing Forecast
10.5.4 Turkey Market Transcriptome Sequencing Forecast
10.6 Global Transcriptome Sequencing Forecast by Type (2026-2031)
10.7 Global Transcriptome Sequencing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Transcriptome Sequencing Forecast
11 Key Players Analysis
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Transcriptome Sequencing Product Offered
11.1.3 Illumina Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Transcriptome Sequencing Product Offered
11.2.3 Thermo Fisher Scientific Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 贰耻谤辞蹿颈苍蝉听厂肠颈别苍迟颈蹿颈肠
11.3.1 贰耻谤辞蹿颈苍蝉听厂肠颈别苍迟颈蹿颈肠 Company Information
11.3.2 贰耻谤辞蹿颈苍蝉听厂肠颈别苍迟颈蹿颈肠 Transcriptome Sequencing Product Offered
11.3.3 贰耻谤辞蹿颈苍蝉听厂肠颈别苍迟颈蹿颈肠 Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 贰耻谤辞蹿颈苍蝉听厂肠颈别苍迟颈蹿颈肠 Main Business Overview
11.3.5 贰耻谤辞蹿颈苍蝉听厂肠颈别苍迟颈蹿颈肠 Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Transcriptome Sequencing Product Offered
11.4.3 Roche Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Bio-Rad
11.5.1 Bio-Rad Company Information
11.5.2 Bio-Rad Transcriptome Sequencing Product Offered
11.5.3 Bio-Rad Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bio-Rad Main Business Overview
11.5.5 Bio-Rad Latest Developments
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Information
11.6.2 Agilent Technologies Transcriptome Sequencing Product Offered
11.6.3 Agilent Technologies Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Agilent Technologies Main Business Overview
11.6.5 Agilent Technologies Latest Developments
11.7 LabCorp
11.7.1 LabCorp Company Information
11.7.2 LabCorp Transcriptome Sequencing Product Offered
11.7.3 LabCorp Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 LabCorp Main Business Overview
11.7.5 LabCorp Latest Developments
11.8 QIAGEN
11.8.1 QIAGEN Company Information
11.8.2 QIAGEN Transcriptome Sequencing Product Offered
11.8.3 QIAGEN Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 QIAGEN Main Business Overview
11.8.5 QIAGEN Latest Developments
11.9 Pacific Biosciences
11.9.1 Pacific Biosciences Company Information
11.9.2 Pacific Biosciences Transcriptome Sequencing Product Offered
11.9.3 Pacific Biosciences Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Pacific Biosciences Main Business Overview
11.9.5 Pacific Biosciences Latest Developments
11.10 Azenta
11.10.1 Azenta Company Information
11.10.2 Azenta Transcriptome Sequencing Product Offered
11.10.3 Azenta Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Azenta Main Business Overview
11.10.5 Azenta Latest Developments
11.11 BGI Genomics
11.11.1 BGI Genomics Company Information
11.11.2 BGI Genomics Transcriptome Sequencing Product Offered
11.11.3 BGI Genomics Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 BGI Genomics Main Business Overview
11.11.5 BGI Genomics Latest Developments
11.12 Novogene
11.12.1 Novogene Company Information
11.12.2 Novogene Transcriptome Sequencing Product Offered
11.12.3 Novogene Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Novogene Main Business Overview
11.12.5 Novogene Latest Developments
11.13 Macrogen
11.13.1 Macrogen Company Information
11.13.2 Macrogen Transcriptome Sequencing Product Offered
11.13.3 Macrogen Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Macrogen Main Business Overview
11.13.5 Macrogen Latest Developments
11.14 Shanghai ZJ Bio-Tech
11.14.1 Shanghai ZJ Bio-Tech Company Information
11.14.2 Shanghai ZJ Bio-Tech Transcriptome Sequencing Product Offered
11.14.3 Shanghai ZJ Bio-Tech Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Shanghai ZJ Bio-Tech Main Business Overview
11.14.5 Shanghai ZJ Bio-Tech Latest Developments
11.15 Tsingke Biotechnology
11.15.1 Tsingke Biotechnology Company Information
11.15.2 Tsingke Biotechnology Transcriptome Sequencing Product Offered
11.15.3 Tsingke Biotechnology Transcriptome Sequencing Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Tsingke Biotechnology Main Business Overview
11.15.5 Tsingke Biotechnology Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂